Safety Profile

Melanotan II Side Effects & Safety

Melanotan II has a higher side effect burden than other peptides due to its non-selective melanocortin activity.

Educational content only. This page is compiled from published research for reference and is not medical advice, diagnosis, or treatment. Readers should verify claims against primary sources and consult a qualified healthcare provider before making any health decisions. Full disclaimer.

Side effects by severity

Serious1 effect

Melanoma risk

Case reports of atypical melanomas in melanotan users. Causality not established but a serious concern.

Common7 effects

Nausea

Particularly in first doses; often severe.

Facial flushing

Melanocortin-mediated.

Loss of appetite

Can be substantial.

Skin darkening

Expected effect; generalized and/or patchy.

Moles/nevi changes

Existing moles may darken or enlarge; new moles may appear.

Spontaneous erections (male)

MC4R activation; can be prolonged.

Yawning

Melanocortin-related; distinctive side effect.

Uncommon2 effects

Dizziness

Transient.

Increased blood pressure

Transient.

Rare1 effect

Priapism

Prolonged erection; requires medical attention.

Contraindications

Personal or family history of melanoma
Numerous or atypical nevi
Active malignancy
Pregnancy and lactation
Known hypersensitivity

Drug interactions

PDE5 inhibitors — additive erection effects; increased priapism risk
Alpha-blockers — unknown combined effect

Special populations

Not FDA approved. Not recommended in any special population. High safety concern profile.

Safety summary

Melanotan II has the highest concerning side effect profile on PeptideMark. Skin cancer concerns, priapism, and significant nausea are all substantial risks. PT-141 (bremelanotide) is a safer selective alternative for sexual function, and it is FDA approved.

Frequently asked

Can Melanotan II cause melanoma?

Case reports describe atypical melanomas in users. Causality has not been proven, but the theoretical mechanism (darkening and proliferation of pigmented lesions) is biologically plausible. Avoid if personal or family history of melanoma.